Bright future ahead for tricuspid regurgitation management - EuroPCR 2022

EuroPCR 2021: The TriClip bRIGHT StudyПодробнее

A patient-focused transcatheter portfolio of options to treat tricuspid regurgitation - EuroPCR 2022Подробнее

Tricuspid regurgitation: a new prospect in the management of patients - GulfPCR-GIM 2022Подробнее

What is the future role of 3D ICE in tricuspid valve intervention? - PCR London Valves 2024Подробнее

“Clear need” for transcatheter options for tricuspid regurgitation - EuroPCR 2022Подробнее

Tricuspid valve lifetime managementПодробнее

Transcatheter tricuspid valve repair: CLASP TR study one-year resultsПодробнее

Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from TriClip bRIGHTПодробнее

A new focus on mitral and tricuspid valve disease - EuroPCR 2022Подробнее

Management of tricuspid valve regurgitation - WebinarПодробнее

Advancing solutions for tricuspid regurgitation patients: introducing TriClip G4 - EuroPCR 2021Подробнее

Tailoring tricuspid regurgitation patient treatment with the PASCAL Precision system - EuroPCR 2023Подробнее

New horizons in tricuspid therapy, the TricValve solution - EuroPCR 2021Подробнее

Expand your mitral portfolio with Tendyne - EuroPCR 2022Подробнее

MCP 60 Seconds With Dr Kyla Lara-Breitinger on Tricuspid RegurgitationПодробнее

TriClip therapy: here now, here to stay - EuroPCR 2022Подробнее

Future is Bright for the Tricuspid Valve: Insights from NapaПодробнее

Embrace the future of mitral and tricuspid repair and replacement - EuroPCR 2021Подробнее

Rhythm management in patients with tricuspid regurgitation - WebinarПодробнее